Esperion(ESPR) - 2022 Q4 - Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2022 Earnings Conference Call February 21, 2023 8:00 AM ET Company Participants Tiffany Aldrich - Associate Director, Corporate Communications Sheldon Koenig - President and Chief Executive Officer JoAnne Foody - Chief Medical Officer Benjamin Halladay - CFO Eric Warren - Chief Commercial Officer Conference Call Participants Serge Belanger - Needham Joseph Thome - Cowen Michael Yee - Jefferies Jason Butler - JMP Securities Jeff Hung - Morgan Stanley Tom Shrader - ...